Preferred Label : ticlopidine;

MeSH definition : An effective inhibitor of platelet aggregation commonly used in the placement of STENTS in CORONARY ARTERIES.;

CISMeF synonym : vitoria brand of ticlopidine hydrochloride; almirall brand of ticlopidine hydrochloride; roche brand of ticlopidine hydrochloride;

MeSH hyponym : 53-32C; ticlodix; ticlid; ticlodone; Ticlopidine Hydrochloride; Hydrochloride, Ticlopidine; 53 32C; 5332C;

MeSH CAS label : Thieno(3,2-c)pyridine, 5-((2-chlorophenyl)methyl)-4,5,6,7-tetrahydro-;

MeSH Related Number : ticlopidine hydrochloride; 53885-35-1 (Ticlopidine hydrochloride); 55142-85-3 (Ticlopidine); A1L4914FMF;

Registry Number MeSH : 55142-85-3;

Related CAS MeSH : A1L4914FMF (Ticlopidine hydrochloride);

Wikipedia link : https://en.wikipedia.org/wiki/Ticlopidine;

Codes EINECS : 259-498-5;

Is substance : O;

UNII : OM90ZUW7M1;

InChIKey : PHWBOXQYWZNQIN-UHFFFAOYSA-N;

Details


Main resources

You can consult :

An effective inhibitor of platelet aggregation commonly used in the placement of STENTS in CORONARY ARTERIES.

http://sfar.org/wp-content/uploads/2018/03/2_Gestion-des-agents-antiplaquettaires-pour-une-procedure-invasive-programmee.pdf
https://doi.org/10.1016/j.anrea.2018.01.002
2018
false
false
false
France
French
platelet aggregation inhibitors
hemorrhage
postoperative complications
platelet aggregation inhibitors
embolism and thrombosis
aspirin
administration, oral
Prasugrel Hydrochloride
risk management
risk assessment
continuity of patient care
patient safety
purinergic P2Y receptor antagonists
purinergic P2Y receptor antagonists
platelet aggregation inhibitors excl. heparin
surgical procedures, operative
blood loss, surgical
perioperative period
ticlopidine
ticlopidine
adenosine
adenosine
Clopidogrel
Ticagrelor

---
https://www.revmed.ch/RMS/2016/RMS-N-520/Double-antiagregation-plaquettaire-pour-le-traitement-et-la-prevention-secondaire-de-la-maladie-coronarienne-Indications-modalites-et-durees-de-traitement
2017
false
false
false
Switzerland
French
journal article
secondary prevention
platelet aggregation inhibitors
coronary disease
coronary disease
Duration of treatment (qualifier value)
hemorrhage
platelet aggregation inhibitors
review of literature
drug therapy, combination
aspirin
administration, oral
treatment outcome
Prasugrel Hydrochloride
ischemia
purinergic P2Y receptor antagonists
purinergic P2Y receptor antagonists
purinergic P2Y12 receptor antagonists
purinergic P2Y12 receptor antagonists
percutaneous coronary intervention
acute coronary syndrome
practice guidelines as topic
ticlopidine
ticlopidine
adenosine
adenosine
Clopidogrel
Ticagrelor

---
https://www.revmed.ch/RMS/2014/RMS-N-412-413/Cardiologie-Tests-de-reactivite-plaquettaire-mise-a-jour-pour-le-praticien
2014
false
false
false
Switzerland
French
journal article
platelet activation
platelet activation
embolism and thrombosis
ticlopidine
ticlopidine
Clopidogrel

---
https://www.minerva-ebp.be/FR/Article/79
2013
true
false
Belgium
French
critical appraisal or critical reading
ticlopidine
ticlopidine
clopidogrel
ticlopidine
diabetes complications
cardiovascular diseases
diabetes mellitus, type 2
purinergic P2Y receptor antagonists
treatment outcome
adenosine diphosphate receptor antagonists
platelet aggregation inhibitors
Clopidogrel

---
http://www.cochrane.org/fr/CD002133
2013
false
true
false
France
United Kingdom
CORONARY STENT, OTHER
anticoagulants
blood vessel prosthesis implantation
review of literature
french abstract
anticoagulants
stents
ticlopidine

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=61276643
2012
France
summary of product characteristics
package leaflet
tablets
ticlopidine

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=66387722
2012
France
summary of product characteristics
package leaflet
tablets
ticlopidine

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=69490318
2012
France
summary of product characteristics
package leaflet
tablets
ticlopidine

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=65989672
2012
France
summary of product characteristics
package leaflet
tablets
ticlopidine

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=68103010
2012
France
summary of product characteristics
package leaflet
ticlopidine
tablets

---
http://www.has-sante.fr/portail/jcms/c_1242864/ticlid
http://www.has-sante.fr/portail/upload/docs/application/pdf/2012-04/ticlid_11042012_avis_ct11901.pdf
http://www.has-sante.fr/portail/jcms/c_517575/ticlid
http://www.has-sante.fr/portail/jcms/c_399346/ticlid-250-mg-comprimes-pellicules-sous-streap-seal-boite-de-30
2012
France
French
evaluation of the transparency committee
CORONARY STENT, OTHER
ticlopidine
administration, oral
insurance, health, reimbursement
Ticlopidine Hydrochloride
ticlopidine
platelet aggregation inhibitors
fibrinolytic agents
treatment outcome
thrombosis
stroke
myocardial infarction
ischemia
coronary artery disease
intermittent claudication
renal dialysis
stents

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=67763864
2012
France
summary of product characteristics
package leaflet
tablets
ticlopidine

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=68691446
2012
France
summary of product characteristics
package leaflet
tablets
ticlopidine

---
https://www.ema.europa.eu/medicines/human/EPAR/Clopidogrel-HCS
2012
United Kingdom
English
French
syndication feed
ischemic attack, transient
peripheral vascular diseases
ticlopidine
platelet aggregation inhibitors
platelet aggregation inhibitors
clopidogrel
tablets
administration, oral
drugs, generic
drug approval
treatment outcome
adult
breast feeding
pregnancy
drug evaluation, preclinical
thrombosis
aged
drug interactions
atherosclerosis
myocardial infarction
acute coronary syndrome
summary of product characteristics
package leaflet
drug evaluation
Clopidogrel
Clopidogrel

---
https://www.ema.europa.eu/medicines/human/EPAR/clopidogrel-apotex-previously-clopidogrel-mylan-pharma
2012
false
United Kingdom
French
English
syndication feed
administration, oral
drug approval
treatment outcome
ticlopidine
platelet aggregation inhibitors
platelet aggregation inhibitors
drugs, generic
adult
clopidogrel
breast feeding
pregnancy
drug evaluation, preclinical
thrombosis
atherosclerosis
myocardial infarction
ischemic attack, transient
peripheral vascular diseases
summary of product characteristics
drug evaluation
package leaflet
Clopidogrel
Clopidogrel

---
https://www.ema.europa.eu/medicines/human/EPAR/clopidogrel-krka-dd-previously-zopya
2012
false
United Kingdom
English
French
syndication feed
clopidogrel
platelet aggregation inhibitors
drug approval
platelet aggregation inhibitors
drug labeling
treatment outcome
tablets
administration, oral
drugs, generic
adult
breast feeding
pregnancy
drug evaluation, preclinical
thrombosis
aged
drug interactions
atherosclerosis
ticlopidine
drug evaluation
package leaflet
summary of product characteristics
Clopidogrel
Clopidogrel

---
https://www.ema.europa.eu/medicines/human/EPAR/Plavix
2011
United Kingdom
English
French
syndication feed
platelet aggregation inhibitors
atherosclerosis
atherosclerosis
treatment outcome
drug evaluation
ticlopidine
clopidogrel
clopidogrel bisulfate
drug evaluation
summary of product characteristics
package leaflet
Clopidogrel

---
https://www.ema.europa.eu/medicines/human/EPAR/Iscover
2011
United Kingdom
English
French
syndication feed
myocardial infarction
arterial occlusive diseases
ticlopidine
ticlopidine
platelet aggregation inhibitors
platelet aggregation inhibitors
treatment outcome
drug evaluation
tablets
stroke
adult
drug approval
drug labeling
atherosclerosis
thrombosis
ticlopidine
acute coronary syndrome
aged
drug interactions
drug evaluation, preclinical
clopidogrel
drug evaluation
summary of product characteristics
package leaflet
Clopidogrel
Clopidogrel

---
https://www.ema.europa.eu/medicines/human/EPAR/clopidogrel-teva-generics-bv
2011
false
United Kingdom
English
French
syndication feed
drugs, generic
administration, oral
ticlopidine
platelet aggregation inhibitors
platelet aggregation inhibitors
tablets
drug approval
treatment outcome
drug evaluation, preclinical
pregnancy
breast feeding
drug interactions
thrombosis
atherosclerosis
myocardial infarction
ischemic attack, transient
peripheral vascular diseases
acute coronary syndrome
clopidogrel
adult
aged
summary of product characteristics
package leaflet
drug evaluation
Clopidogrel
Clopidogrel

---
https://medicalforum.ch/fr/detail/doi/fms.2011.07544/
2011
false
Switzerland
French
journal article
ticlopidine
platelet aggregation inhibitors
clopidogrel
drug interactions
proton pump inhibitors
Clopidogrel

---
https://www.revmed.ch/RMS/2010/RMS-251/Le-clopidogrel-et-ses-differents-sels-existe-t-il-une-pertinence-clinique
2010
false
true
false
Switzerland
ticlopidine
ticlopidine
ticlopidine
ticlopidine
ticlopidine
platelet aggregation inhibitors
Relevance
journal article
Clopidogrel

---
http://www.has-sante.fr/portail/upload/docs/application/pdf/2010-08/duoplavin_-_ct-8086.pdf
http://www.has-sante.fr/portail/jcms/c_971029/duoplavin
http://www.has-sante.fr/portail/upload/docs/application/pdf/2012-09/duoplavin_ct_8086.pdf
2010
France
French
English
drug combinations
administration, oral
platelet aggregation inhibitors
ticlopidine
aspirin
combinations
insurance, health, reimbursement
adult
aged
treatment outcome
acute coronary syndrome
myocardial infarction
acute disease
thrombosis
atherosclerosis
ticlopidine
clopidogrel bisulfate
evaluation of the transparency committee
Clopidogrel

---
http://www.has-sante.fr/portail/jcms/c_1000850/duoplavin-association-fixe-de-clopidogrel-et-dacide-acetylsalicylique-anti-agregants-plaquettaires
http://www.has-sante.fr/portail/upload/docs/application/pdf/2010-08/duoplavin_-_ct-8086.pdf
2010
France
French
evaluation of the transparency committee
guidelines for drug use
ticlopidine
platelet aggregation inhibitors
drug combinations
aspirin
thrombosis
atherosclerosis
adult
combinations
acute coronary syndrome
myocardial infarction
acute disease
insurance, health, reimbursement
treatment outcome
administration, oral
clopidogrel bisulfate
Clopidogrel

---
https://www.revmed.ch/RMS/2010/RMS-235/Evaluation-de-l-efficacite-biologique-du-clopidogrel-genotype-ou-phenotype
2010
Switzerland
French
journal article
ticlopidine
platelet aggregation inhibitors
genotype
phenotype
Clopidogrel

---
https://www.ema.europa.eu/medicines/human/EPAR/Clopidogrel-Teva-Pharma
2010
United Kingdom
French
English
syndication feed
ticlopidine
platelet aggregation inhibitors
platelet aggregation inhibitors
drug approval
drug labeling
administration, oral
drugs, generic
clopidogrel
adult
atherosclerosis
drug interactions
drug evaluation, preclinical
thrombosis
aged
treatment outcome
pregnancy
breast feeding
pharmacovigilance note
drug evaluation
package leaflet
Clopidogrel
Clopidogrel

---
https://www.ema.europa.eu/medicines/human/EPAR/clopidogrel-bgr-previously-zylagren
2010
false
United Kingdom
English
French
syndication feed
ticlopidine
platelet aggregation inhibitors
clopidogrel
platelet aggregation inhibitors
tablets
administration, oral
drugs, generic
drug approval
drug labeling
treatment outcome
thrombosis
atherosclerosis
adult
aged
drug interactions
pregnancy
breast feeding
drug evaluation, preclinical
drug evaluation
package leaflet
summary of product characteristics
Clopidogrel
Clopidogrel

---
https://www.ema.europa.eu/medicines/human/EPAR/Clopidogrel-BMS
2009
United Kingdom
English
French
syndication feed
ticlopidine
ticlopidine
platelet aggregation inhibitors
platelet aggregation inhibitors
ticlopidine
adult
aged
tablets
administration, oral
myocardial infarction
acute coronary syndrome
peripheral vascular diseases
ischemia
myocardial ischemia
drug approval
drug labeling
treatment outcome
drug interactions
breast feeding
pregnancy
drug evaluation, preclinical
clopidogrel
drug evaluation
summary of product characteristics
package leaflet
Clopidogrel
Clopidogrel

---
http://www.cbip.be/nieuws/artikel.cfm?welk=329
2009
Belgium
French
proton pump inhibitors
ticlopidine
drug interactions
clopidogrel
proton pump inhibitors
drug information
Clopidogrel

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=69223411
2009
France
French
ticlopidine
platelet aggregation inhibitors
clopidogrel
summary of product characteristics
package leaflet

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=62806062
2009
France
French
ticlopidine
platelet aggregation inhibitors
clopidogrel
summary of product characteristics
package leaflet

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=67088979
2009
France
French
ticlopidine
platelet aggregation inhibitors
clopidogrel
summary of product characteristics
package leaflet

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=62280908
2009
France
French
ticlopidine
platelet aggregation inhibitors
clopidogrel
summary of product characteristics
package leaflet

---
http://www.cbip.be/Folia/Index.cfm?FoliaWelk=F35F01F
2008
Belgium
French
platelet aggregation inhibitors
ticlopidine
acute coronary syndrome
ticlopidine
journal article
Clopidogrel

---
https://rmlg.uliege.be/article/1470
2006
Belgium
French
clinical trials as topic
aspirin
middle aged
platelet aggregation inhibitors
ticlopidine
ticlopidine
journal article
Clopidogrel

---
https://www.minerva-ebp.be/fr/article/763
2005
false
minerva-ebm.be
Belgium
French
Evidence-Based medicine
stroke
aspirin
ticlopidine
ticlopidine
ticlopidine
aspirin
platelet aggregation inhibitors
aspirin
platelet aggregation inhibitors
ischemic attack, transient
platelet aggregation inhibitors
treatment outcome
ticlopidine
critical appraisal or critical reading
journal article
Clopidogrel

---
Nous contacter.
02/06/2024


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.